プレマーケットデータ（自動更新なし）20日平均DV $41,554?
Earnings 2026-09-0252W high -56.2%52W low +82.8%Fwd PER 0.0xMarket cap $2MAvg volume 12K
Company Overview
NewcelX Ltd., a biotechnology company, engages in developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company was founded in 2008 and is headquartered in Zurich, Switzerland.
Earnings & Financials
Earnings actuals
| Period | EPS | Revenue | FCF |
|---|
| 2025 Q4 | 1.29 | $0 | -$1,984 |
| 2025 Q2 | -10.50 | $0 | -$2M |
| 2024 Q4 | -26.30 | $0 | -$3M |
| 2024 Q2 | -1.94 | $0 | -$2M |
| 2023 Q4 | -1.40 | $0 | -$2,387 |
| 2023 Q2 | -2.00 | $0 | -$7M |
| 2022 Q4 |
